ImmunityBio, Inc., a clinical-stage immunotherapy company, announced that Executive Chairman and Global Chief Scientific and Medical Officer Patrick Soon-Shiong, M.D., has been invited to deliver the 2023 David Packard Award Lecture at the Uniformed Services University of the Health Sciences.
IDEAYA Biosciences, Inc. announced the pricing of an underwritten public offering of common stock and pre-funded warrants.
IDEAYA Announces Pricing of Public Offering – April 25, 2023 Read More »
MAIA Biotechnology, Inc. announced the pricing of an underwritten public offering of 2,222,200 shares of its common stock at a public offering price of $2.25 per share, for gross proceeds of approximately $5 million, before deducting underwriting discounts and other offering expenses.
MAIA Biotechnology, Inc. Announces Pricing of Public Offering – April 25, 2023 Read More »
CEO Roy Jakobs expressed confidence in the company’s outlook for the year ahead and said setting aside the funds to resolve a U.S. class action lawsuit was “an important step in addressing the litigation related to the recall.”
Philips says revenue rises 6%, sees €575M in recall-related legal costs Read More »
The material can mold to the heart, unlike the more rigid implanted pacemakers used today. While still in early stages of development, the tattoo approach could significantly improve cardiac care.
Graphene ‘tattoo’ pacemaker senses and treats irregular heart beats in rats Read More »
Eplontersen halted ATTRv-PN disease progression and improved quality of life through 66 weeks. The drug has a PDUFA date of Dec. 22, 2023.
Ionis and AstraZeneca Seek to Challenge Alnylam with New ATTR Data Read More »
It’s the largest enforcement action against COVID-19 healthcare fraud schemes to date, according to regulators.
DOJ charges 18 in COVID healthcare frauds totaling $490M Read More »
Pexels. Poner la tecnología más avanzada al servicio de la cadena productiva del sector apícola. Este es el propósito que viene desarrollándose en el Centro de Investigación y Tecnología Agroalimentaria de Aragón (CITA), que …
La tecnología blockchain llega a la miel en España Read More »
Unos científicos han descubierto por vez primera una toxina en el genoma de un mosquito, presente allí mediante un mecanismo genético insólito. El equipo de Walter Jesús Lapadula, de la Universidad Nacional de San Luis en Argentina, ha investigado en profu …
Descubren una toxina en el genoma del mosquito del dengue Read More »
To give the FDA more time to evaluate updates to quizartinib’s proposed REMS program, the regulator is pushing the target action date to July 24.
FDA Delays Verdict for Daiichi Sankyo’s Quizartinib Read More »
